1. Home
  2. FRES vs ALBT Comparison

FRES vs ALBT Comparison

Compare FRES & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • ALBT
  • Stock Information
  • Founded
  • FRES 2010
  • ALBT 2014
  • Country
  • FRES United States
  • ALBT United States
  • Employees
  • FRES N/A
  • ALBT N/A
  • Industry
  • FRES Medical Specialities
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FRES Health Care
  • ALBT Health Care
  • Exchange
  • FRES Nasdaq
  • ALBT Nasdaq
  • Market Cap
  • FRES 6.4M
  • ALBT 9.5M
  • IPO Year
  • FRES 2020
  • ALBT N/A
  • Fundamental
  • Price
  • FRES $2.53
  • ALBT $0.42
  • Analyst Decision
  • FRES
  • ALBT
  • Analyst Count
  • FRES 0
  • ALBT 0
  • Target Price
  • FRES N/A
  • ALBT N/A
  • AVG Volume (30 Days)
  • FRES 10.9K
  • ALBT 84.1K
  • Earning Date
  • FRES 09-17-2024
  • ALBT 08-12-2024
  • Dividend Yield
  • FRES N/A
  • ALBT N/A
  • EPS Growth
  • FRES N/A
  • ALBT N/A
  • EPS
  • FRES N/A
  • ALBT N/A
  • Revenue
  • FRES $2,345,304.00
  • ALBT $959,516.00
  • Revenue This Year
  • FRES N/A
  • ALBT N/A
  • Revenue Next Year
  • FRES N/A
  • ALBT N/A
  • P/E Ratio
  • FRES N/A
  • ALBT N/A
  • Revenue Growth
  • FRES N/A
  • ALBT 6.08
  • 52 Week Low
  • FRES $2.36
  • ALBT $0.24
  • 52 Week High
  • FRES $41.00
  • ALBT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • FRES 34.73
  • ALBT 44.94
  • Support Level
  • FRES $2.56
  • ALBT $0.45
  • Resistance Level
  • FRES $3.40
  • ALBT $0.49
  • Average True Range (ATR)
  • FRES 0.35
  • ALBT 0.05
  • MACD
  • FRES -0.03
  • ALBT -0.01
  • Stochastic Oscillator
  • FRES 12.69
  • ALBT 8.04

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: